[H]C1(C(C)N)CCC(N)C(OC2([H])C(N)CC(N)C(OC3([H])OCC(C)(O)C(NC)C3O)C2O)O1.[H]C1(C(C)NC)CCC(N)C(OC2([H])C(N)CC(N)C(OC3([H])OCC(C)(O)C(NC)C3O)C2O)O1.[H]C1(CN)CCC(N)C(OC2([H])C(N)CC(N)C(OC3([H])OCC(C)(O)C(NC)C3O)C2O)O1
Assay: DRUGMATRIX inhibits MAO-A using Kynuramine as substrate with a single protein target (Homologous). The assay is In vitro, with Binding as the type description and BTI-TN-5B1-4 as the cell type. Does the molecule work for this assay?